United States

People: Genomic Health Inc (GHDX.OQ)

GHDX.OQ on NASDAQ Stock Exchange Global Select Market

22 Apr 2019
Change (% chg)

$1.55 (+2.50%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Baker, Julian 

Mr. Julian C. Baker serves as Lead Independent Director of the Company, effective March 1, 2012. Mr. Baker’s firm manages long-term investment funds, focused on publicly traded life sciences companies, for major university endowments and foundations. Mr. Baker’s career as a fund-manager began in 1994 when he and his brother co-founded a biotechnology investing partnership with the Tisch Family. Previously, Mr. Baker was employed from 1988 to 1993 by the private equity investment arm of Credit Suisse First Boston Corporation. Mr. Baker is also a director of Acadia Pharmaceuticals, Inc., Idera Pharmaceuticals, Inc. and Incyte Corporation, where he serves as lead independent director. Mr. Baker holds an A.B. in Social Studies from Harvard University.

Basic Compensation

Total Annual Compensation, USD 5,000
Restricted Stock Awards, USD 40,000
Long-Term Incentive Plans, USD --
All Other, USD 132,727
Fiscal Year Total, USD 177,727

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Kimberly Popovits


Gordon Cole


Steven Shak


Phillip Febbo


Laura Kammeyer


Frederic Pla

As Of  30 Dec 2017